New Long-Acting painkiller could cut opioid use after keyhole surgery
NCT ID NCT07458256
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a long-acting numbing drug (liposomal bupivacaine) plus standard bupivacaine works better than standard bupivacaine alone for pain after laparoscopic surgery. About 190 adults having gallbladder, hernia, or appendix surgery will receive one of the two treatments. The goal is to see if the combination reduces the need for rescue pain medication within 48 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- liposomal bupivacaine plus bupivacaine hydrochloride
- What this could lead to
- If it works, this could provide longer-lasting pain relief after laparoscopic surgery, reducing the need for opioid painkillers.
- What could go wrong
- This is a mid-sized trial (190 people) comparing two local anesthetics, so any benefit may be modest. Results may not apply to other surgeries or pain types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LAPAROSCOPIC SURGERY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tiantan Hospital
RECRUITINGBeijing, Beijing Municipality, 100070, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new mesh implant fix pelvic organ prolapse better?
- New opioid aims to cut Post-Surgery nausea without sacrificing pain relief
- Wrist surgery pain relief showdown: which block works best?
- New monitoring method may keep seniors breathing easier after surgery
- New pain block could keep hip surgery patients comfortable for days
- New pain block could cut opioid use after lung transplants